- Home
- SPCE vs FENC Comparison
SPCE vs FENC Comparison
Compare SPCE & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPCE | FENC |
|---|---|---|
| Founded | 2017 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.3M | 258.5M |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | SPCE | FENC |
|---|---|---|
| Price | $3.16 | $8.09 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $9.22 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 5.5M | 189.1K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,661,000.00 | ★ $38,790,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,656.89 | $70.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.18 | $4.68 |
| 52 Week High | $6.77 | $9.92 |
Technical Indicators
Market Signals| Indicator | SPCE | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 41.21 | 52.61 |
| Support Level | $2.92 | $7.43 |
| Resistance Level | $4.04 | $7.83 |
| Average True Range (ATR) | 0.30 | 0.28 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 14.28 | 81.06 |
Price Performance
Historical ComparisonAbout SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.